Accès ouvert · CC BY

Stakeholder perspectives on the feasibility and uptake of the cardiovascular polypill in South Africa

Article scientifique 2026 Sciences de la santé Autre

Résumé

ABSTRACT Background Cardiovascular disease (CVD) remains the leading global cause of death, disproportionately affecting low- and middle- income countries (LMICs). Complex treatment regimens compromise adherence and health system delivery. Cardiovascular (CV) polypills, combining a statin with two/three antihypertensives, can improve adherence, risk factor control, and outcomes. However, uptake remains low despite inclusion in the 2023 World Health Organization Essential Medicine List. In South Africa, where CVD and multimorbidity are rising, polypills are unavailable in the public sector, with limited use privately. Understanding stakeholder perspectives is essential to guide implementation. Objective To explore stakeholder perspectives regarding the feasibility, acceptability, and potential uptake of CV polypills in South African primary care. Methods We conducted semi-structured interviews with 15 purposively sampled stakeholders from clinical, policy, regulatory, industry, and advocacy sectors. Data were thematically analysed using ATLAS.ti, with reflexivity, peer debriefing, and participant validation to ensure rigour. Results Participants acknowledged polypill’s potential to improve adherence, simplify treatment, and strengthen prevention, but identified key barriers, including formulation challenges, limited incentives, regulatory complexity, inequitable access, and insufficient local evidence. Pharmacological strategies were viewed as complementary to prevention measures such as risk screening and lifestyle modifications. Participants advocated for context-specific research, coordinated policy action, streamlined regulation, equitable procurement, and advocacy-led demand generation, with government leadership deemed essential. Conclusion CV polypills offer a promising strategy to improve CVD outcomes in LMICs, but impact depends on overcoming systemic barriers and generating local evidence. Coordinated, multisectoral action is critical to achieve scalable and equitable implementation in South Africa and similar settings. Contribution This study advances understanding of the clinical, behavioural, and system-level factors shaping the adoption of CV polypill in South Africa, providing actionable insights to guide future research, inform policy innovation, and support scalable implementation of cardiovascular prevention strategies across LMIC settings.

Citer ce document

Leong, T., Schmidt, B., Zühlke, L., Curran, R., Simmonds, I., Ntusi, N., Kredo, T., & Fairall, L. (2026). Stakeholder perspectives on the feasibility and uptake of the cardiovascular polypill in South Africa. Journal of Public Health in Africa. https://doi.org/10.4102/jphia.v17i1.1745

Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)

Accès au document

Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter

Voir l'article sur le site de la revue

Licence et provenance

Licence : CC BY

Notice moissonnée depuis OpenAlex le 02/10/2026. Le document reste hébergé par sa source.
Voir le document à la source →

Statistiques

Consultations (hors robots) : 18

Téléchargements (hors robots) : 0

Méthode de comptage